Principles of Laser Therapy

Clinical Ophthalmic Oncology

Volumn , Issue , 2007, Pages 37-39

  Sacu, Stefan ^a   Schmidt Erfurth, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874101416     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3167-3.50012-7     Document Type: Chapter

References (20)

1. L'Esperance FJ Ophthalmic lasers 1983, 340-350. CV Mosby, St Louis.
2. Voke J Lasers and their use in ophthalmology - Part 3 http://www.optometry.com.
3. Kohnen T Laser in eye surgery http://www.krager.com/gazette.
4. Pomerantzeff O, Kaneko H, Donovan R, et al. Effect of the ocular media on the main wavelengths of argon laser emission. Invest Ophthalmol Vis Sci 1976, 15:70-77.
5. Peyman GA, Raichand M, Zeimer RC Ocular effects of various laser wavelengths. Surv Ophthalmol 1984, 28:391-404.
6. Laser in ophthalmology. Basic, diagnostic and surgical aspects 2003, Kugler Publications, The Hague. F. Fankhauser, S. Kwasniewska (Eds.).
7. Dewey D Corneal and retinal energy density with various laser beam delivery systems and contact lenses. SPIE 1991, 1423:105-116.
8. Marshall J, Bird A A comparative histopathologic study of argon and krypton laser irradiation of the human retina. Br J Ophthalmol 1979, 63:657-668.
9. L'Esperance F Clinical photocoagulation with the organic dye laser. A preliminary communication. Arch Ophthalmol 1985, 103:1312-1316.
10. Noyori K, Shimizu K, Trokel S Ophthalmic laser therapy 1992, Igaku-Shoin, Tokyo.
11. Folk JC, Pulido JS Laser photocoagulation of the retina and choroid 1997, American Academy of Ophthalmology, San Francisco.
12. Blanco G, Soparkar CN, Jordan DR, et al. The ocular complications of periocular laser surgery. Curr Opin Ophthalmol 1999, 10:264-269.
13. Oosterhuis JA, Journee-de Korver HG, Kakebeeke-Kemme HM, Bleeker JC Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol 1995, 113:315-321.
14. Reichel E, Berrocal AM, Ip M, et al. Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration. Ophthalmology 1999, 106:1908-1914.
15. Schmidt-Erfurth U, Michels S, Barbazetto I, et al. Photodynamic effects on choroidal neovascularization and physiological choroid. Invest Ophthalmol Vis Sci 2002, 43:830-841.
16. Treatment of Age-Related Macular degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP report 2. Arch Ophthalmol 2001, 119:198-207.
17. Schmidt-Erfurth UM, Kusserow C, Barbazetto IA, Laqua H Benefits and complications of photodynamic therapy of papillary capillary hemangiomas. Ophthalmology 2002, 109:1256-1266.
18. Michels S, Michels R, Beckendorf A, et al. Photodynamic therapy for choroidal hemangioma. Long-term results. Ophthalmologe 2004, 101:569-575.
19. Schmidt-Erfurth U, Schlötzer-Schrehard U, Cursiefen C, et al. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3 and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2003, 44:4473-4480.
20. Schmidt-Erfurth U, Michels S Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin. Ophthalmology 2003, 110:1306-1314.